Hyperglycemia induced by the 5-HT receptor agonist, 5-methoxytryptamine, in rats: involvement of the peripheral 5-HT 2A receptor

By Yamada J.   Sugimoto Y.   Yoshikawa T.   Horisaka K.  

European Journal of Pharmacology, Vol. 323, Iss. 2, 1997-04 ,pp. : 235-240

Elsevier

Access to resources Recommend Favorite

Characterisation of agonist binding on human 5-HT 2C receptor isoforms

By Quirk K.   Lawrence A.   Jones J.   Misra A.   Harvey V.   Lamb H.   Revell D.   Porter R.H.P.   Knight A.R.  

European Journal of Pharmacology, Vol. 419, Iss. 2, 2001-05 ,pp. : 107-112

Elsevier

Access to resources Recommend Favorite

DOI, a 5-HT 2 receptor agonist, induces renal vasodilation via nitric oxide in anesthetized dogs

By Tian R.-X.   Kimura S.   Kondou N.   Fujisawa Y.   Zhou M.-S.   Yoneyama H.   Kosaka H.   Rahman M.   Nishiyama A.   Abe Y.  

European Journal of Pharmacology, Vol. 437, Iss. 1, 2002-02 ,pp. : 79-84

Elsevier

Access to resources Recommend Favorite

Enhancement of antipsychotic-like properties of the dopamine D 2 receptor antagonist, raclopride, by the additional treatment with the 5-HT 2 receptor blocking agent, ritanserin, in the rat

By Wadenberg M.-L.   Salmi P.   Jimenez P.   Svensson T.   Ahlenius S.  

European Neuropsychopharmacology, Vol. 6, Iss. 4, 1996-11 ,pp. : 305-310

Elsevier

Access to resources Recommend Favorite

Atropine acts in the ventral striatum to reduce raclopride-induced catalepsy

By Alcock S.J.   Hemsley K.M.   Crocker A.D.  

European Journal of Pharmacology, Vol. 424, Iss. 3, 2001-07 ,pp. : 179-187

Elsevier

Access to resources Recommend Favorite